GENEREX BIOTECHNOLOGY CORP: 10-K filed 2019-11-12
What GENEREX BIOTECHNOLOGY CORP reported in its annual report filed 2019-11-12 (fiscal FY 2019): 40 published measures, 86 facts as tagged in accession 0001607062-19-000429.
This filing
- Form
- 10-K (annual report)
- Filed
- 2019-11-12
- Fiscal period
- fiscal FY 2019
- Accession
- 0001607062-19-000429 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENEREX BIOTECHNOLOGY CORP filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 49,635,991 | USD | |
| At 2018-07-31 | 6,606,854 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 37,889,494 | USD | |
| At 2018-07-31 | 50,191,522 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 7,672,599 | USD | |
| At 2018-07-31 | -43,584,668 | USD | |
| At 2017-07-31 | -79,876,231 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 298,485 | USD | |
| At 2019-01-07 | 61,857 | USD | |
| At 2018-07-31 | 1,046,365 | USD | |
| At 2017-07-31 | 2,879,165 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -11,006,794 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 35,948,698 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -9,574,193 | USD | 365 |
| 2017-08-01 to 2018-07-31 | -2,293,214 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 289,917 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 8,552 | USD | 365 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 6,203,761 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 703,244 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 6,508,726 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 453,694 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 2,318,793 | USD | 365 |
| 2017-08-01 to 2018-07-31 | -8,552 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | -418,727,875 | USD | |
| At 2018-07-31 | -409,386,468 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 48,360,127 | shares | 365 |
| 2017-08-01 to 2018-07-31 | 1,068,101 | shares | 365 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 48,360,127 | shares | 365 |
| 2017-08-01 to 2018-07-31 | 2,591,129 | shares | 365 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -0.19 | USD/shares | 365 |
| 2017-08-01 to 2018-07-31 | 34.02 | USD/shares | 365 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -0.19 | USD/shares | 365 |
| 2017-08-01 to 2018-07-31 | 14.02 | USD/shares | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 499,993 | USD | |
| At 2019-01-07 | 444 | USD | |
| At 2018-07-31 | 31,536 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 3,006,203 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 0 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -24,345,441 | USD | 365 |
| 2017-08-01 to 2018-07-31 | -2,495,609 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 973,535 | USD | |
| At 2018-07-31 | 1,188,246 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 7,087,502 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 583,594 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 28,946,023 | USD | |
| At 2018-07-31 | 25,229,015 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 38,297,573 | USD | |
| At 2019-01-07 | 13,485,758 | USD | |
| At 2018-07-31 | 0 | USD | |
| At 2017-12-28 | 0 | USD |
Net finite-lived intangible assets
Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 9,834,269 | USD | |
| At 2018-07-31 | 3,211,037 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 26,410,749 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 3,198,853 | USD | 365 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 363,008 | USD | |
| At 2018-07-31 | 12,075 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 2,065,308 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 703,244 | USD | 365 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 4,138,453 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 0 | USD | 365 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 1,748,882 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 839,147 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 62,290,940 | shares | |
| At 2018-07-31 | 22,430,121 | shares |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 797,216 | USD | |
| At 2018-07-31 | 798,422 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 639,920 | USD | |
| At 2018-07-31 | 52,745 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 132,927 | USD | |
| At 2018-07-31 | 21,209 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-07-31 | 1,082,952 | USD | |
| At 2017-12-28 | 276,380 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -9,341,407 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 36,334,098 | USD | 365 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 21,292,678 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 2,359,706 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 170,605 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 21,782 | USD | 365 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 426,440 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 23,780 | USD | 365 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 255,835 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 2,571 | USD | 365 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | 750,241 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 33,555 | USD | 365 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-08-01 to 2019-07-31 | -1,126,424 | USD | 365 |
| 2017-08-01 to 2018-07-31 | 2,040 | USD | 365 |
Inspect the source
- Entity
- GENEREX BIOTECHNOLOGY CORP / CIK 0001059784
- Captured
- SEC response SHA-256
a8779b8c3aa8286320834b30d50af09999238cecacb9e7883d21e11477763a4d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001059784.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))